SanaCurrents Case Studies

//SanaCurrents Case Studies

ARMO Biosciences (ARMO) – SanaCurrents Case Study

By |2018-11-20T15:51:29-04:00August 25th, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|

ARMO Biosciences (ARMO) listed in January 2018 at $17 per [...]

Eiger Biopharmaceuticals (NASDAQ:EIGR) – SanaCurrents Case Study

By |2018-11-20T15:51:17-04:00August 10th, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|

Eiger Biopharmaceuticals (NASDAQ:EIGR), a company developing treatment for rare diseases, [...]

MyoKardia (NASDAQ:MYOK) – SanaCurrents Case Study

By |2018-11-25T13:52:30-04:00August 3rd, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|

MyoKardia (NASDAQ:MYOK), a leading precision cardiovascular medicine company, reported good [...]

Dynavax’s (NASDAQ:DVAX) – SanaCurrents Case Study

By |2018-11-20T15:37:46-04:00August 1st, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|

Dynavax's (NASDAQ:DVAX) BLA application for its Hepatitis B vaccine first [...]

Zogenix (NASDAQ:ZGNX) – SanaCurrents Case Study

By |2018-11-20T15:51:47-04:00July 31st, 2018|Health Care Equipment & Services, Healthcare, Hot Research, Insights, Pharmaceutical & Biotechnology, SanaCurrents Case Studies|

California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had [...]